Harbin Fuerjia Technology Crecimiento futuro
Future controles de criterios 1/6
Harbin Fuerjia Technology is forecast to grow earnings and revenue by 8.8% and 11% per annum respectively. EPS is expected to grow by 7.1% per annum. Return on equity is forecast to be 12.7% in 3 years.
Información clave
8.8%
Tasa de crecimiento de los beneficios
7.1%
Tasa de crecimiento del BPA
Crecimiento de los beneficios de Medical Equipment | 27.5% |
Tasa de crecimiento de los ingresos | 11.0% |
Rentabilidad financiera futura | 12.7% |
Cobertura de analistas | Good |
Última actualización | 28 Oct 2024 |
Actualizaciones recientes sobre el crecimiento futuro
No hay actualizaciones
Previsiones de crecimiento de beneficios e ingresos
Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
---|---|---|---|---|---|
12/31/2026 | 2,634 | 884 | N/A | 864 | 6 |
12/31/2025 | 2,374 | 811 | N/A | 757 | 7 |
12/31/2024 | 2,132 | 743 | N/A | 843 | 7 |
9/30/2024 | 2,060 | 727 | 577 | 709 | N/A |
6/30/2024 | 2,005 | 736 | 669 | 754 | N/A |
3/31/2024 | 1,970 | 742 | 662 | 774 | N/A |
12/31/2023 | 1,934 | 749 | 706 | 826 | N/A |
9/30/2023 | 1,794 | 735 | 481 | 730 | N/A |
6/30/2023 | 1,821 | 843 | 515 | 902 | N/A |
3/31/2023 | 1,788 | 845 | 481 | 912 | N/A |
1/1/2023 | 1,769 | 847 | 500 | 899 | N/A |
3/31/2022 | 1,657 | 794 | 632 | 786 | N/A |
12/31/2021 | 1,650 | 806 | 643 | 802 | N/A |
12/31/2020 | 1,585 | 648 | 668 | 671 | N/A |
12/31/2019 | 1,342 | 661 | 692 | 726 | N/A |
12/31/2018 | 373 | 200 | 214 | 218 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: 301371's forecast earnings growth (8.8% per year) is above the savings rate (2.9%).
Beneficios vs. Mercado: 301371's earnings (8.8% per year) are forecast to grow slower than the CN market (25.8% per year).
Beneficios de alto crecimiento: 301371's earnings are forecast to grow, but not significantly.
Ingresos vs. Mercado: 301371's revenue (11% per year) is forecast to grow slower than the CN market (14% per year).
Ingresos de alto crecimiento: 301371's revenue (11% per year) is forecast to grow slower than 20% per year.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: 301371's Return on Equity is forecast to be low in 3 years time (12.7%).